Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
OpenUpdated: Oct 30, 2025
Summary
The grant aims to support collaborative research projects that address chronic comorbidities and delayed posttreatment effects of cancer therapies, focusing on identifying mechanisms and developing therapeutic approaches to minimize these adverse sequelae. Eligible applicants include government entities, for-profit and nonprofit organizations, educational institutions, and various other organizations, including those serving Native American populations. Application details are not specified in the provided text; interested parties should refer to the full opportunity announcement for more information.
Full Description
Description
Eligibility
Eligible applicants
Government
- County governments
- Special district governments
- State governments
- City or township governments
- Public and Indian housing authorities
- Federally recognized Native American tribal governments
Business
- For-profit organizations other than small businesses
- Small businesses
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Education
- Private institutions of higher education
- Independent school districts
- Public and state institutions of higher education
Miscellaneous
- Other
Additional information
Grantor contact information
Description
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Recommended Resource
Grant Writing Services on Fiverr
Top PickStruggling with grant applications? Get expert help from professional freelance writers on Fiverr — from research and proposal drafts to compliance review and submission. Secure funding faster with proven talent.